Differential associations of statin and fibrate treatment with carotid arterial remodeling

American Journal of Hypertension

Volumn 18, Issue 11, 2005, Pages 1476-1481

  Chironi, Gilles ^a   Simon, Alain ^a,b   Gariepy, Jérome ^a   Balice, Maria ^a   Del Pino, Muriel ^a   Levenson, Jaime ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Arterial remodeling; Cardiovascular risk factors; Carotid artery; Fibrate derivatives; Intima media thickness; Statins

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BEZAFIBRATE; CERIVASTATIN; CIPROFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CAROTID ARTERY DISEASE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE DURATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTILIPEMIC AGENTS; BEZAFIBRATE; BODY MASS INDEX; CAROTID ARTERIES; CHOLESTEROL, HDL; CLOFIBRIC ACID; COHORT STUDIES; DYSLIPIDEMIAS; FATTY ACIDS, MONOUNSATURATED; FEMALE; GEMFIBROZIL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRAVASTATIN; PROCETOFEN; PYRIDINES; PYRROLES; RISK FACTORS; SIMVASTATIN; TREATMENT OUTCOME; TUNICA INTIMA; TUNICA MEDIA;

EID: 27644583417     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.019     Document Type: Article

References (26)

1. H.N. Hodis, W.J. Mack, J. Barth Carotid intima-media thickness as a surrogate end point for coronary artery disease Circulation 94 1996 2311 2312
2. A. Simon, J. Gariepy, G. Chironi, J.L. Megnien, J. Levenson Intima-media thickness a new tool for diagnosis and treatment of cardiovascular risk J Hypertens 20 2002 159 169
3. D.H. Blankenhorn, R.H. Selzer, D.W. Crawford, J.D. Barth, C.R. Liu, C.H. Liu, W.J. Mack, P. Alaupovic Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound Circulation 88 1993 20 28
4. C.D. Furberg, H.P. Adams Jr, W.B. Applegate, R.P. Byington, M.A. Espeland, T. Hartwell, D.B. Hunninghake, D.S. Lefkowitz, J. Probstfield, W.A. Riley Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group Effect of lovastatin on early carotid atherosclerosis and cardiovascular events Circulation 90 1994 1679 1687
5. R. Salonen, K. Nyyssonen, E. Porkkala, J. Rummukainen, R. Belder, J.S. Park, J.T. Salonen Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries Circulation 92 1995 1758 1764
6. H.N. Hodis, W.J. Mack, L. LaBree, R.H. Selzer, C. Liu, C. Liu, P. Alaupovic, H. Kwong-Fu, S.P. Azen Reduction in carotid arterial wall thickness using lovastatin and dietary therapy a randomized controlled clinical trial Ann Intern Med 124 1996 548 556
7. S. MacMahon, N. Sharpe, G. Gamble, H. Hart, J. Scott, J. Simes, H. White LIPID Trial Research Group Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis results of the LIPID Atherosclerosis Substudy Circulation 97 1998 1784 1790
8. D. Baldassarre, F. Veglia, C. Gobbi, G. Gallus, A. Ventura, G. Crepaldi, M. Fisicaro, S. Rimondi, G. Ricci, M. Mancini, M.G. Bong, S. Collatina, C.R. Sirtori Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels the carotid atherosclerosis Italian ultrasound study Atherosclerosis 151 2000 575 583
9. E. De Groot, J.W. Jukema, A.D. Montauban van Swijndregt, A.H. Zwinderman, R.G. Ackerstaff, A.F. van der Steen, N. Bom, K.I. Lie, A.V. Bruschke B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings a report of the Regression Growth Evaluation Statin Study (REGRESS) J Am Coll Cardiol 31 1998 1561 1567
10. T.J. Smilde, S. van Wissen, H. Wollersheim, M.D. Trip, J.J. Kastelein, A.F. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP) a prospective, randomised, double blind trial Lancet 357 2001 577 581
11. A.J. Taylor, S.M. Kent, P.J. Flaherty, L.C. Coyle, T.T. Markwood, M.N. Vernalis ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness Circulation 106 2002 2055 2060
12. E.J. Topol Intensive statin therapy - a sea change in cardiovascular prevention N Engl J Med 350 2004 1562 1564
13. National Education Cholesterol Program Detection, Evaluation, and Treatment of High blood cholesterol in Adults (Adults Treatment Panel III) Circulation 106 2002 3143 3421
14. S. Graf, J. Gariepy, M. Massonneau, R.L. Armentano, S. Mansour, J.G. Barra, A. Simon, J. Levenson Experimental and clinical validation of arterial diameter waveform and intimal media thickness obtained from B-mode ultrasound image processing Ultrasound Med Biol 25 1999 1353 1363
15. A. Simon, J. Gariepy, D. Moyse, J. Levenson Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes Circulation 103 2001 2949 2954
16. I.N. Mikgdalis, B. Gerolimou, G. Kozanidou, G. Voudouris, S.M. Hatzigakis, A. Petroupoulos Effect of gemfibrozil on early carotid athersosclerosis in diabetic patients with hyperlipidaemia Int Angiol 16 1997 258 261
17. [No authors listed] Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes the Diabetes Atherosclerosis Intervention Study, a randomized study Lancet 357 2001 905 910
18. J. Gariepy, J. Salomon, N. Denarie, F. Laskri, J.L. Megnien, J. Levenson, A. Simon Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort the AXA Study Arterioscler Thromb Vasc Biol 18 1998 584 590
19. [No authors listed] The recognition and management of hyperlipidaemia in adults a policy statement of the European Atherosclerosis Society Eur Heart J 9 1988 571 600
20. R.S. Rosenson, C.C. Tangney Antiatherothrombotic properties of statins implications for cardiovascular event reduction J Am Med Assoc 279 1998 1643 1650
21. A. Corsini, M. Mazzotti, M. Raiteri, M.R. Soma, G. Gabbiani, R. Fumagalli, R. Paoletti Relationship between mevalonate pathway and arterial myocyte proliferation in vitro studies with inhibitors of HMG-CoA reductase Atherosclerosis 101 1993 117 125
22. S. Keidar, M. Aviram, I. Maor, J. Oiknine, J.G. Brook Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages in vitro and in vivo studies Br J Clin Pharmacol 38 1994 513 519
23. G. O'Driscoll, D. Green, R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131
24. G. Chironi, J. Gariepy, N. Denarie, M. Balice, J.L. Megnien, J. Levenson, A. Simon Influence of hypertension on early carotid artery remodeling Arterioscler Thromb Vasc Biol 23 2003 1460 1484
25. J.R. Crouse, U. Goldbourt, G. Evans, J. Pinsky, A.R. Sharrett, P. Sorlie, W. Riley, G. Heiss The ARIC Investigators Arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement Stroke 25 1994 1354 1359
26. H.N. Hodis, W.J. Mack, L. LaBree, R.H. Selzer, C.R. Liu, C.H. Liu, S.P. Azen The role of carotid arterial intima-media thickness in predicting clinical coronary events Ann Intern Med 128 1998 262 269